(See the editorial commentary by Saul, on pages 171-3.)
Background. Plasmodium falciparum merozoite surface protein (MSP) 3 is an asexual blood-stage malaria vaccine candidate antigen. Sequence polymorphisms divide alleles into 2 major types, but the adaptive and immunological significance of the types has not been defined.
Methods. One hundred one msp3 allele sequences were sampled from 2 populations living in areas where malaria is endemic and were analyzed for evidence of natural selection. Recombinant antigens representing fulllength sequences of different allelic types and a relatively conserved C-terminal region were produced, to evaluate immunization-induced antibody responses in mice and protective associations for naturally acquired antibodies in a cohort of 319 Gambian children under surveillance for malaria.
Results. Frequency-based statistical analyses indicated that polymorphisms are maintained by balancing selection in each of the 2 populations studied. Immunization of mice with full-length MSP3 antigens induced predominantly type-specific antibodies, and a large proportion of naturally acquired antibodies to MSP3 in humans also discriminated between the alleles. Among Gambian children, antibodies to allele-specific and conserved epitopes in MSP3 were associated prospectively with protection from clinical malaria, even after adjustment for age and for the presence of antibodies to other merozoite antigens.
Conclusions. A vaccine incorporating both major allelic types of this promising candidate antigen could be particularly useful for induction of protective immunity in infants and young children.
Development of an effective blood-stage vaccine against malaria remains a top priority for global health. Plasmodium falciparum merozoite surface protein (MSP) 3, which is encoded by a single locus on parasite chromosome 10 (Pf10_0345 in the genome browser at http: //www.plasmodb.org/), is a nonintegral surface-associated protein that elicits antibody responses during natural malaria infection and experimental immunization [1] [2] [3] [4] [5] [6] [7] . Naturally acquired antibodies to MSP3 were first shown to mediate antibody-dependent cel-lular inhibition (ADCI) of parasites in vitro [3] , and IgG3 antibodies to the C-terminal region were then shown to be associated with reduced incidence of malaria in longitudinal cohort studies [4, 5] . Aotus monkeys immunized with recombinant full-length MSP3 produced high antibody titers and were protected against experimental challenge with P. falciparum expressing a homologous MSP3 type [2] . Antibodies with antiparasite activity have also been produced in Saimiri monkeys by immunization with a recombinant antigen based on the C-terminal region of MSP3, although most of the animals did not control a challenge infection [7] . Immunization of human volunteers with a 96-aa synthetic peptide corresponding to part of the C-terminal region produced antibodies that showed activity in vitro in ADCI assays and in vivo in humanized SCID mice [1, 6] .
The C-terminal region of P. falciparum MSP3 (corresponding to aa 196-379 in the K1 allele sequence) is highly conserved [8] and is involved in trafficking the protein onto the merozoite surface through an interaction with the acidic basic repeat antigen, or ABRA (also known as MSP9) [9] . By contrast, most of the remainder of the sequence (corresponding to aa 52-195 of K1 MSP3) is polymorphic, with several large indels and many amino acid substitutions [8] defining 2 major allele types (K1 like and 3D7 like), between which there is only very limited recombination [10] .
It is important to determine whether a vaccine candidate antigen that is polymorphic in nature is under selection from protective immune responses or whether the polymorphisms are neutral or related to other selective processes. Here, 3 lines of evidence for the importance of allele-specific immunity to MSP3 are presented. First, sequence-based population genetic analyses on samples from 2 populations provide evidence for the maintenance of polymorphisms within MSP3 because of balancing selection. Second, most antibodies that are elicited by immunization of mice with full-length MSP3 recombinant proteins react with parasites in an allele-specific manner. Finally, naturally acquired antibodies to polymorphic epitopes of MSP3, as well as antibodies to conserved epitopes, are prevalent in a population living in an area of endemicity and are associated with protection from malaria.
MATERIALS AND METHODS
Amplification and sequencing of the msp3 gene from P. falciparum isolates. Alleles of msp3 were amplified from P. falciparum genomic DNA prepared from blood samples from 48 patients with malaria seen in Nigeria (at the University College Hospital, Ibadan, in 1996) and 50 patients seen in Thailand (at the Hospital for Tropical Diseases, Mahidol University, Bangkok, in 2000). These samples were chosen from a larger set collected for analysis of parasite DNA polymorphism, because they appeared to contain unmixed (single clone) P. falciparum infections [11] and were used for study of other gene sequences [12, 13] . The region of the msp3 gene corresponding to codons 21-379 of the K1 sequence was amplified using 40 rounds of polymerase chain reaction (PCR) with the primers pfmsp3F60 (5 -AAATAATGTTGCTAGTAAAGAAATTG-3 ) and pfmsp3R1147 (5 -AATGATTTTTAAAATATTTGGAT-AATTC-3 ); cycling conditions were denaturation at 95ЊC for 30 s, annealing at 56ЊC for 45 s, and extension at 72ЊC for 90 s. Products were purified and cloned into the pGEM TEasy vector (Promega Corporation) for transformation and growth in supercompetent JM109 Escherichia coli (Promega). Three plasmid clones were selected for each PCR product and the msp3 gene insert was sequenced, by use of BigDye 3.1 chemistry and an ABI 3730 automated capillary sequencer (Applied Biosystems). Sequences were checked in SeqMan II (version 5.07; DNAStar). For 3 parasite isolates containing 11 msp3 allele, additional plasmid clones were selected and sequenced until each allelic haplotype was represented by 3 separate clones. Allele sequences were aligned using the Clustal W algorithm in MegAlign (version 5.07; DNAstar).
Population genetic analysis. Nucleotide sequence alignments of all alleles sampled from each population were analyzed by Tajima's D test [14] using the program DNAsp (version 4.0) [15] . Positive values of Tajima's D that are significantly different from zero support a hypothesis of balancing selection acting to maintain polymorphisms at intermediate frequencies in a population. The test was performed on all sequences from each population separately and also on the 3D7-like and K1-like allele sequence subsets from each population separately. The population recombination parameter C (equivalent to 4N e c, where N e is the effective population size and c is the rate of recombination per generation) [16] and v (equivalent to 4N e m, where m is the mutation rate per generation) were also calculated using DNAsp (version 4.0), and an estimation of the ratio of the recombination rate compared with the mutation rate was calculated by dividing C by v [17] . Evidence for recombination was tested by evaluating the correlation of linkage disequilibrium with nucleotide map distance, using the pairwise program in the LDHAT package [18] .
Production and purification of MSP3 recombinant proteins. The amino acid sequences of the recombinant proteins are given in figure 1 . The coding sequence of msp3 (starting at codon 2 and ending at the stop codon) was amplified from genomic DNA from the P. falciparum 3D7 and K1 lines by use of the primer sequences msp3BamHIF (5 -GGGGGATCCAAA-AGTTTTATAAATATTACTCTTTCA-3 ) and msp3SalIR (5 -GGGGTCGACAAGGATTTATAGAATATAAAAGAAATC-3 ) that incorporate restriction sites for cloning (BamHI and SalI; restriction sites shown in primer sequences by underscoring). A region encoding the C-terminal sequence (codons 234-354 of the 3D7 allele) was also amplified from 3D7 genomic DNA by use of the primers msp3(700c)BamHIF (5 -GGGGGATC- . E, The 40 K1-type alleles alone. F, The 10 3D7-type alleles alone. Window sizes used were 100 bp with a 25-bp step size, with sites with gaps being excluded from each window and, hence, playing no role in the calculations. Windows that gave a significant D value, indicating balancing selection ( ), P ! .05 are indicated above the relevant window midpoint by an asterisk. The nucleotide diversity indices (p) for all msp3 sequences in the Nigerian and Thai populations were 0.045 and 0.041, respectively (excluding indel sites). The K1-like major allelic type was determined by the presence of a 13-codon insertion representing codons 52-64 of the K1 allele together with linked polymorphisms downstream in the sequence, and there was a much higher diversity amongst the K1-like alleles than among the 3D7-like alleles within each population (values of p for K1-like and 3D7-like allelic sequences were, respectively, 0.028 and 0.004 for Nigeria and 0.021 and 0.002 for Thailand).
CGATGAGAAGGAAGAAG-3 ) and msp3SalIR. Amplifications were performed using the Expand High Fidelity PCR Kit (Roche), with 40 rounds of PCR and annealing at 56ЊC. Products were cloned into the pGEM-T Easy PCR cloning vector, and sequences that were identical to the published sequences for 3D7 and K1 were excised by use of BamHI and SalI and were cloned into the pMAL-c2X vector (New England Biolabs) for expression in E. coli TB1 cells as maltose binding protein (MBP)-fused proteins, which were purified from sonicated cell extracts by affinity chromatography with amylase resin (New England Biolabs). Additionally, BamHI and EcoRI digestion (EcoRI site in the pGEM-T Easy vector) was used to excise sequences for cloning into the pGEX-2T vector (Amersham Biosciences) and for expression in E. coli BL21+ cells as glutathione S-transferase (GST)-fused proteins, which were purified from sonicated cell extracts with Glutathione Sepharose Fast Flow resin (Amersham Pharmcia Biotech).
Immunization of mice and assay of murine antibodies.
Outbred MF1 mice were immunized with full-length 3D7 MSP3 (MBP-fused protein), full-length K1 MSP3 (MBP-fused protein), or MBP (fusion tag alone). For each immunization, 50 mg of protein in 50 mL of PBS was mixed with 150 mL of Imject alum (Perbio Science UK) for 30 min at room temperature before intraperitoneal injection. Three immunizing doses were administered at monthly intervals, with final blood collection 12 days after the third immunization. Specific antiparasite reactivity of murine serum was assessed using the immunofluorescent antibody test [19] . Multiwell slides of P. falciparum schizonts were prepared from cultured parasites (3D7 and K1). Serial doubling dilutions (1:50 to 1:6400) of serum were used to determine the highest dilution giving clear positive fluorescence of the schizonts as determined by 2 investigators independently.
Human serum and surveillance for malaria. Serum sam- ples collected in June 1996 (immediately before the annual malaria transmission season) from 319 Gambian children (age range, 3-7 years) resident in Basse were tested for antibodies to MSP3. The subjects were the same as those included previously in investigations of the role played by antibodies to MSP1 and MSP2 antigens in protection against malaria [11, 20, 21] (serum samples from 18 of 337 tested previously were no longer available) and were monitored by active and passive case detection from July to November 1996 (the major part of the malaria season), to identify cases of clinical malaria. Clinical malaria was defined as a febrile episode (axillary temperature 137.5ЊC) together with P. falciparum parasitemia 15000 organisms/mL of blood, the most commonly used definition in this area [11, 22] . Serum samples were also collected from 40 Gambian adults resident in Brefet village who were asymptomatic at the time of collection and from 20 donors in the United Kingdom who had never been exposed to malaria. Collection of these serum samples for these studies was approved by the Scientific Coordinating Committee of the Medical Research Council (MRC) Laboratories in The Gambia and by the Joint MRC/Gambian Government Ethical Committee.
ELISAs. Individual recombinant proteins were used to coat wells of Dynex 4HBX plates (Dynex Technologies) at 50 ng/ well. ELISAs to detect specific IgG were performed with 100 mL of diluted human serum (final concentration, 1:1000) in duplicate wells following the same protocol as used for studies of antibodies to other merozoite antigens [11, 20, 21] . Reactivity to purified GST and MBP fusion tags was subtracted to adjust for the minor reactivity to these polypeptides. Serum samples were scored as positive for serum IgG to an antigen if reactivity was higher than the mean reactivity plus 3 SDs for serum samples obtained from the 20 malaria-naive control subjects in the United Kingdom. Competition ELISAs were conducted as above, except that serum samples were incubated for 5 h with a competing antigen before being exposed to plate-bound antigen. For analysis of serum samples obtained from Gambian adults, a range of amounts of competing antigen were used per well (0, 10, 50, 100, 500, and 1000 ng), and 1000 ng (i.e., at a concentration of 10 mg/mL) was then used per well for competition assays of serum samples from Gambian children, because this was shown to completely compete for all homologous antibodies in the serum samples from adults.
Statistical analysis of the association between antibody positivity and subsequent malaria morbidity. Epidemiological and antibody data were combined in Stata (version 8.2; StataCorp). Univariate logistic regression was used to test the association between antibody positivity before the malaria transmission season and subsequent malaria morbidity during the transmission season. Multivariate logistic regression was used to adjust for the age of the subjects and for antibody positivity to 2 other sets of recombinant merozoite proteins that were Figure 6 . Differential recognition of merozoite surface protein (MSP) 3 allelic forms by human antibodies. A-C, Competition ELISA profiles of 3 serum samples from Gambian adults showing the presence of antibodies to 3D7-specific epitopes (strong reactivity) and K1-specific epitopes (weak reactivity) (A), K1-specific and conserved epitopes (B), and conserved epitopes only (C). Serum samples were preincubated with differing amounts of K1 or 3D7 MSP3 polypeptides (as recombinant maltose binding protein-fused proteins) before they were allowed to bind to plate-bound heterologous and homologous polypeptides. Profiles involving K1 and 3D7 plate-bound antigen are shown by black and white diamonds, respectively, and profiles involving K1 and 3D7 competing antigen are shown by solid and dashed lines, respectively. D, Scatterplot of serum IgG reactivity to the full-length K1 and 3D7 MSP3 proteins in 319 Gambian children.
investigated previously in this cohort [11, 20, 21] . The resultant odds ratios (calculated by logistic regression) were then converted to relative risks (the ratio of the percentage of people with an episode of malaria in the antibody-positive and -negative groups) [23] .
RESULTS
Significant departure from neutrality with respect to allelic variation in msp3 sequences in both Nigerian and Thai populations. Fifty-one alleles were sampled from the Nigerian population (3 of the 48 blood samples selected for the study as single-clone infections contained 2 allelic forms of the msp3 gene because of mixed-clone infections not detected by screening genotypes at other loci), of which there were 41 different allele sequences. Fifty alleles were sampled from the Thai population (each of these serum samples contained only a single allele, as was expected from screening other loci), of which there were 20 different allele sequences. An alignment of 1063 nucleotide sites for all 101 alleles contained 358 polymorphic sites in total, comprising 91 single-nucleotide polymorphism (SNP) sites without alignment gaps (indels), 36 SNPs at sites that also covered indels, and 231 other indels (figure 2).
Both the Nigerian and the Thai parasite populations exhibited a significant departure from neutral equilibrium expectations for the msp3 gene (Tajima's D value, 2.34 and 2.22, respectively; for each). These analyses were dominated P ! .05 by the major dimorphic sequence, as shown by elevated D values in sliding windows covering sequences encoding nt 157-608 ( figure 3A and 3D ) and a low level of recombination in this region of the sequence (figure 4). When the K1-like allele sequences were analyzed separately, there were 2 regions with Tajima's D values that were significantly greater than zero ( ) in the Thai and Nigerian samples independently. The P ! .05 first of these occurs at the start of the polymorphic region (nt 198-325), and the second encodes the relatively conserved extreme C-terminal part of the sequence ( figure 3B and 3E) . When the 3D7-like allele sequences were analyzed separately, it was only in the region encoding the C-terminal part that a value significantly greater than zero was seen in the Nigerian population ( figure 3C and 3F) . [11, 20, 21] . For MSP1 block 2, 3 binary variables were used (Ab positivity to 3D7, MAD20, and RO33 recombinant antigens); for MSP2, 2 binary variables were used (Ab positivity to type A and type B recombinant antigens). Positive serum samples had mostly IgG1 and IgG3 reactivity, with similar trends as for IgG-although with less significance, as the numbers positive for each subclass were lower (data not shown).
Allele-specific antibodies to MSP3 elicited by immunization with recombinant MSP3. The soluble fraction of each GSTfused MSP3 protein migrated as either a single (3D7) band or 2 (K1) bands close to the predicted molecular weight when purified and analyzed by SDS-PAGE (figure 5B), although only ∼10% of the total GST-fused MSP3 protein was soluble, limiting the yield that could be obtained using this expression system. By contrast, the MBP-fused proteins were readily expressed, highly soluble, and easily purified, with the 3D7 and C-terminal MSP3 proteins each migrating as a single band and with the K1 MSP3 protein migrating as a major band of the expected size together with 3 smaller bands presumed to be products of proteolysis (figure 5B). Subsequently, except where stated, the MBP-fused MSP3 proteins were used because of their greater yield.
Mice immunized with the recombinant full-length MBPfused MSP3 K1 or 3D7 proteins all produced antibodies that reacted with P. falciparum schizonts, as determined by immunofluorescence. The mice immunized with the K1 MSP3 recombinant protein produced antibodies specific for K1 parasites (only 1 mouse produced antibodies reactive with 3D7 parasites at low titer) ( figure 5C ). Mice immunized with 3D7 MSP3 recombinant protein produced antibodies against both 3D7 and K1 parasites, although titers of antibodies to K1 were generally much lower than those to 3D7 ( figure 5D ).
High frequency of allele-specific anti-MSP3 antibodies in serum from humans living in areas of endemicity. Competition ELISAs using the 3D7 and K1 MBP-fused MSP3 proteins showed that naturally acquired antibodies present in the serum of Gambian adults recognize conserved and polymorphic epitopes. For example, figure 6A shows that serum sample 25 contained antibodies that bind only to the 3D7 form of MSP3 in addition to antibodies that bind only to the K1 form (these were at much lower concentrations). Figure 6B shows results obtained with serum sample 03, which contained K1-specific antibodies as well as antibodies recognizing epitopes shared between the 2 proteins. Serum sample 19 ( figure 6C ) contained only antibodies to conserved epitopes. Competition ELISAs using the GST-fused K1 and 3D7 MSP3 proteins gave similar results (optical density values from competition ELISAs for all 28 serum samples from adults having reactivity to MSP3 are given in table 1).
Association of antibodies to allele-specific and conserved epitopes of MSP3 with protection against malaria in Gambian children. Of the 319 Gambian children sampled in June 1996, 205 (64%) and 193 (61%), respectively, had positive serum IgG reactivity to the full-length K1 and 3D7 MSP3 recombinant proteins, whereas 71 (22%) had reactivity to the C-terminal recombinant protein. The presence of allele-specific antibodies is shown in a scatterplot analysis of optical density values for antibodies to the K1 and 3D7 full-length MSP3 proteins ( figure  6D ). Visual examination of the scatterplot shows that many children with high antibody levels (OD 11.0) recognized either Table 3 . Association between relative levels of antibodies (Abs) to different parts of merozoite surface protein (MSP) 3 before the malaria transmission season (June) and the occurrence of an episode of clinical malaria during the transmission season (July-November) among 319 Gambian children. the K1 or the 3D7 protein more strongly than the other. Competition ELISAs were then performed with the full-length proteins; these assays showed that 95 children (30%) had K1 allelespecific antibodies and 97 (30%) had antibodies that were specific for the 3D7 allele (table 2) .
In a univariate analysis, positive antibody reactivity to MSP3 antigens before the malaria transmission season was associated with a reduced relative risk of a subsequent episode of malaria (table 2) . Age was associated with protection from malaria in this cohort of Gambian children, as in other populations, and was therefore accounted for in a multivariate logistic regression analysis; adjustment was also performed for antibody reactivity to polymorphic antigens previously studied in this cohort and shown to be associated with protection (antigens representing block 2 sequences of MSP1 and full-length MSP2 proteins). The presence of antibodies to the full-length MSP3 antigens remained significantly associated with reduced risk of malaria, as did the presence of antibodies to K1-type-specific MSP3 epitopes. Antibodies to 3D7-type-specific MSP3 epitopes and the C-terminal of MSP3 antigen were not as significantly associated with reduced risk of malaria (table 2) .
Analysis of antibody levels among those who were antibody positive showed that high (above the median) levels to both full-length antigens and allele-specific epitopes were more strongly associated with protection than were low levels of antibodies (table 3) . This was in contrast to antibodies to the recombinant protein representing the C-terminal part of MSP3, for which high levels of antibodies showed no increased association with protection, compared with low but positive antibody levels.
DISCUSSION
The present results indicate that the P. falciparum MSP3 antigen is a promising vaccine candidate and encourage the inclusion of allele-specific sequences together with conserved sequences in a formulation for immunization. Frequency-dependent selection caused by protective immune responses can best explain the nonneutral patterns of the within-population sequence diversity seen in the msp3 gene in this study. In the absence of such selection, the observed positive values of Tajima's D index would be predicted to occur only after a severe reduction in population size [24] , whereas evidence indicates a historical population expansion that gives negative values of the index under neutrality [25] . A previous analysis of 19 msp3 sequences from laboratory isolates of diverse origin also gave a positive Tajima's D value, although this was tentative, because pooling of samples across populations is not recommended [26] . In addition to the major allelic dimorphism that dominates the allelic profile of msp3, there are polymorphisms within each of the 2 major types that show nonneutral frequency distributions. The majority of these are specific to the K1-like allelic sequences, which have a much higher diversity than the 3D7-like allelic sequences. The major dimorphic alleles of msp3 are highly divergent, indicating that they have either been maintained in the species for millions of years or that one of the allelic types was introduced by introgression from another species [10] (most likely the 3D7-like type, because this has less within-type diversity). The major allelic types of msp3 are maintained intact within populations, with an unusually low level of recombination. The estimated ratio of recombination to mutation parameters in msp3 (C/v ratio !0.03 in each population in figure 4 ) is far lower than values for other antigen loci that are highly polymorphic in P. falciparum (eba175 and ama1 genes on chromosomes 7 and 11, respectively, have C/v ratios of 2 and 14 in the Nigerian population) [13, 27] , differences that exceed the large-scale pattern of heterogeneity in recombination parameters across a chromosome [28] . The existence of large indels and the high divergence of the msp3 dimorphic sequences may prevent crossing over at meiosis, or there may be very strong selection against recombinants (possibly a miniature form of immunitydriven strain structure operating at a very low genetic map distance) [29] .
Most Gambian children with high anti-MSP3 antibody levels showed a bias in reactivity toward either the K1 or 3D7 type recombinant protein, suggesting that allele-specific epitopes in MSP3 may induce stronger antibody responses than do conserved epitopes. The presence of such antibodies in individuals before a transmission season was associated with a reduced risk of subsequent clinical malaria, and higher antibody levels were associated with a more reduced risk, associations that remained significant after adjustment for antibodies to other polymorphic P. falciparum surface antigens (MSP1 and MSP2) and age. Antibody positivity to the more conserved C-terminal region of MSP3 was also associated with protection, supporting the results of previous studies [4, 5] , although there was not a more reduced risk among those with higher antibody levels. The Cterminal recombinant protein did not contain part of the central conserved sequence that has been represented in some synthetic peptides and may independently be important [4, 5] . However, the possibility that polymorphic sequences in MSP3 are more immunogenic than conserved sequences is supported by the immunizations of mice with full-length constructs, which induced mainly allele-specific antibodies reactive with parasite schizonts. A previous study showed that immunization of Aotus monkeys with full-length MSP3 resulted in strong antibody responses capable of controlling homologous challenge infection, so it would be of interest to see whether antibodies from these animals were directed predominantly toward polymorphic or conserved epitopes [2] .
A field trial of an experimental vaccine containing a single allelic type of another P. falciparum dimorphic merozoite protein (MSP2) had a selective effect against parasites with that type [30] . If the full-length MSP3 molecule is developed as a vaccine, it would be preferable to include both major allelic forms (at least one representative allele of both K1-like and 3D7-like types), although this adds to the challenging process of product development [31] . MSP3 appears to be under natural immune selection, so such a vaccine might protect infants and younger children in areas of endemicity (a minority of those with P. falciparum infection although the majority of those with clinical cases) without greatly increasing the overall selection pressure on the locus. Such a vaccine could thus have long-term usefulness, combining the effect of allele-specific immunity together with that induced to the conserved C-terminal region of MSP3.
